Market Analysis — CLIFTON-FINE HOSPITAL
NY market | 5 hospitals | HHI: nan (Competitive)
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
5
Hospitals in Market
216
Total Beds
$0.2B
Market Revenue
Competitive
HHI: nan
None
Moat Rating (2/10)
#4
Market Share Rank
Competitive Moat (Mauboussin Framework)
Based on "Measuring the Moat" adapted for healthcare. Score 0-10: wide (8+), narrow (5-7), none (<5).
Scale Advantageweak
Switching Costslow
Market Share4.8%
Top 3 Concentration95.2%
Network Density2.31
Margin vs Market+10.2%
Bed Util vs Market+1.9%
What This Means
This hospital has a none moat — no moat — commoditized market position, pricing power limited. The NY market is competitive — many players, value creation must come from operations not market power (HHI: nan).
Implications: Operational improvements are the primary value driver — see the EBITDA bridge. Compare against peers via comparables or see the full NY market.
Top Competitors
| Hospital | Beds | Revenue | Rev Share | Bed Share |
|---|---|---|---|---|
| CLAXTON HEPBURN MEDICAL CENTER | 38 | $107M | 56.1% | 17.6% |
| MASSENA MEMORIAL HOSPITAL | 25 | $48M | 25.4% | 11.6% |
| GOUVERNEUR HOSPITAL | 25 | $26M | 13.7% | 11.6% |
| ST. LAWRENCE P.C. | 108 | $nanM | nan% | 50.0% |
Regional Payer Mix
■ Medicare 24%■ Medicaid 12%■ Commercial 64%